▪ Introduction
Tren Med 200 by Pharma Nevis is a long-acting injectable anabolic formulation containing 200 mg/mL of Trenbolone Enanthate. It is formulated to support anabolic recovery in clinical and veterinary environments, particularly in the management of catabolic conditions, severe undernutrition, surgical rehabilitation, or tissue-wasting syndromes.
Trenbolone Enanthate promotes enhanced nitrogen retention, protein synthesis, and muscle preservation, while minimizing breakdown during metabolic distress. Its long-acting enanthate ester ensures a sustained hormonal release, making it suitable for less frequent administration while maintaining stable plasma concentrations.
Pharma Nevis produces Tren Med 200 under strict GMP-compliant standards, guaranteeing sterility, compound purity, and batch-to-batch consistency for professional use in regulated medical protocols.
▪ Product Details
-
Active Ingredient: Trenbolone Enanthate
-
Concentration: 200 mg/mL
-
Form: Injectable solution (intramuscular)
-
Brand: Pharma Nevis
-
Packaging: 10 mL multi-dose vial
-
Use: Licensed clinical or research use only
▪ Pharmacokinetics
-
Half-life: Approximately 7–10 days
-
Onset: Gradual, sustained anabolic activity
-
Dosing Interval: Typically once or twice weekly under medical supervision
▪ Administration Guidelines
-
Typical Dosage: As directed by a licensed medical professional
-
Route: Intramuscular injection
-
Frequency: Weekly or biweekly, depending on clinical protocol
▪ Disclaimer
This product is intended for licensed medical professionals and is not suitable for individuals under 18, pregnant or breastfeeding women, or for non-therapeutic or recreational use. Use must comply with regional laws, medical guidelines, and institutional policies.
